Total Payments
$17,061
2024 Payments
$2,639
Companies
35
Transactions
1,068
Medicare Patients
1,033
Medicare Billing
$319,558
Payment Breakdown by Category
Food & Beverage$16,926 (99.2%)
Education$135.09 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,926 | 1,049 | 99.2% |
| Education | $135.09 | 19 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,986 | 115 | $0 (2024) |
| Lundbeck LLC | $1,527 | 102 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,355 | 79 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $1,317 | 70 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $929.19 | 69 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $866.23 | 49 | $0 (2024) |
| ABBVIE INC. | $837.07 | 52 | $0 (2024) |
| ITI, Inc. | $828.97 | 47 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $798.63 | 58 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $785.44 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,639 | 164 | Lundbeck LLC ($275.05) |
| 2023 | $2,760 | 146 | ITI, Inc. ($424.43) |
| 2022 | $2,659 | 160 | Janssen Pharmaceuticals, Inc ($357.29) |
| 2021 | $2,279 | 147 | AbbVie Inc. ($322.81) |
| 2020 | $1,248 | 81 | Sunovion Pharmaceuticals Inc. ($230.37) |
| 2019 | $1,639 | 124 | Otsuka America Pharmaceutical, Inc. ($306.80) |
| 2018 | $1,965 | 123 | Otsuka America Pharmaceutical, Inc. ($394.67) |
| 2017 | $1,871 | 123 | Otsuka America Pharmaceutical, Inc. ($430.42) |
All Payment Transactions
1,068 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: CNS | ||||||
| 12/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.58 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: ADHD | ||||||
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $13.25 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/03/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Neuroscience | ||||||
| 11/28/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: CNS | ||||||
| 11/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Central Nervous System | ||||||
| 11/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: ADHD | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.41 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $1.87 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: ADHD | ||||||
| 11/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $4.93 | General |
| Category: CNS | ||||||
| 11/12/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: CNS | ||||||
| 11/11/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $13.46 | General |
| Category: ADHD | ||||||
| 11/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: CNS | ||||||
| 10/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.49 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $0.88 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 222 | 1,269 | $113,832 | $70,534 |
| 2022 | 2 | 251 | 1,361 | $120,529 | $79,004 |
| 2021 | 2 | 274 | 1,456 | $128,948 | $83,945 |
| 2020 | 2 | 286 | 1,648 | $145,695 | $86,075 |
Total Patients
1,033
Total Services
5,734
Medicare Billing
$319,558
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 639 | $63,900 | $39,103 | 61.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 109 | 630 | $49,932 | $31,431 | 62.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 128 | 684 | $68,400 | $43,851 | 64.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 123 | 677 | $52,129 | $35,153 | 67.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 139 | 732 | $73,200 | $46,841 | 64.0% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 135 | 724 | $55,748 | $37,105 | 66.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 145 | 834 | $83,400 | $43,319 | 51.9% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 141 | 814 | $62,295 | $42,756 | 68.6% |
About Dr. Saad Khan, M.D
Dr. Saad Khan, M.D is a Psychiatry healthcare provider based in Creve Coeur, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1093707218.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Saad Khan, M.D has received a total of $17,061 in payments from pharmaceutical and medical device companies, with $2,639 received in 2024. These payments were reported across 1,068 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($16,926).
As a Medicare-enrolled provider, Khan has provided services to 1,033 Medicare beneficiaries, totaling 5,734 services with total Medicare billing of $319,558. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Creve Coeur, MO
- Active Since 08/16/2005
- Last Updated 03/18/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1093707218
Products in Payments
- REXULTI (Drug) $3,291
- LATUDA (Drug) $1,333
- VRAYLAR (Drug) $1,282
- CAPLYTA (Drug) $1,078
- INVEGA SUSTENNA (Drug) $902.63
- INGREZZA (Drug) $842.67
- APLENZIN (Drug) $589.22
- TRINTELLIX (Drug) $576.01
- AUSTEDO (Drug) $496.18
- Fanapt (Drug) $487.08
- ARISTADA (Drug) $476.90
- Equetro (Drug) $464.02
- SPRAVATO (Drug) $394.18
- Trintellix (Drug) $384.54
- HETLIOZ (Drug) $345.02
- Azstarys (Drug) $287.70
- Auvelity (Drug) $275.49
- JORNAY PM (Drug) $273.75
- Dyanavel XR (Drug) $267.84
- Adzenys XR-ODT (Drug) $260.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.